2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors
出版年份 2021 全文链接
标题
2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors
作者
关键词
COVID-19, SARS-CoV-2, RdRp, Nucleotide analog inhibitor, Remdesivir, 2-((1H-indol-3-yl)thio)-N-Phenyl-acetamides
出版物
ANTIVIRAL RESEARCH
Volume 196, Issue -, Pages 105209
出版商
Elsevier BV
发表日期
2021-11-19
DOI
10.1016/j.antiviral.2021.105209
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- RNA-dependent RNA polymerase (RdRp) inhibitors: the current landscape and repurposing for the COVID-19 pandemic
- (2021) Lei Tian et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase
- (2021) Quanjie Li et al. Acta Pharmaceutica Sinica B
- A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase
- (2021) Jianyuan Zhao et al. ANTIVIRAL RESEARCH
- Quinoline and Quinazoline Derivatives Inhibit Viral RNA Synthesis by SARS-CoV-2 RdRp
- (2021) Jianyuan Zhao et al. ACS Infectious Diseases
- Discovery and optimization of 2-((1H-indol-3-yl)thio)-N-benzyl-acetamides as novel SARS-CoV-2 RdRp inhibitors
- (2021) Guo-Ning Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structural basis for RNA replication by the SARS-CoV-2 polymerase
- (2020) Quan Wang et al. CELL
- Structure of replicating SARS-CoV-2 polymerase
- (2020) Hauke S. Hillen et al. NATURE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure of the RNA-dependent RNA polymerase from COVID-19 virus
- (2020) Yan Gao et al. SCIENCE
- A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19
- (2020) Steffen Jockusch et al. ANTIVIRAL RESEARCH
- Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
- (2020) Ashleigh Shannon et al. ANTIVIRAL RESEARCH
- Drug discovery strategies for SARS-CoV-2
- (2020) Zeenat A Shyr et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19
- (2020) Minchen Chien et al. JOURNAL OF PROTEOME RESEARCH
- Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach
- (2020) Syed Ovais Aftab et al. Journal of Translational Medicine
- RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19
- (2020) Yi Jiang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Global Landscape of SARS-CoV-2 Genomes, Variants, and Haplotypes in 2019nCoVR
- (2020) Shuhui Song et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Design and synthesis of 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as novel dual inhibitors of respiratory syncytial virus and influenza virus A
- (2019) Guo-Ning Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA
- (2017) François Ferron et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis and functional analysis of the SARS coronavirus nsp14–nsp10 complex
- (2015) Yuanyuan Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics
- (2013) Everett Clinton Smith et al. PLoS Pathogens
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now